SAILER CARL purchased 21.9% of their position (24.63K shares) of ACURX PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $25.0K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 1/8/2025ACC: 0001104659-25-002053
+49.26K
Net shares
Net buyer
$25.0K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
49.26K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+24.63K
Price / share
$1.01
Trade value
$25K
% of position
21.9%
1/6/2025
112.55K→137.18K
Total
Net shares
+24.63K
Net value
$25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/6/2025 | P · Purchase | +24.63K | $1.01 | $25K | 21.9% | 112.55K | 137.18K |
| Total | +24.63K | $25K | ||||||
Derivative Transactions1
Warrants for Common Stock
Direct
Converts to
Common Stock
24.63K shares
Shares
+24.63K
Strike price
0.90
Held after
24.63K
Exercisable
—
1/6/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrants for Common Stock Direct | Common Stock24.63K shares | 1/6/2025 | P · Purchase | +24.63K | 0.90 | — | 24.63K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned5K
Total
5K indirect5K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 5K | Indirect |
| Total | 5K | 5K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported